Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-08-26

Clinical Trial Update: Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating placement of a radiofrequency-based plasma microdebridement device for plantar fasciitis and Achilles tendinopathy has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Radiofrequency-based plasma microdebridement device

Snippet

Sponsor: ArthroCare Corporation | Conditions: Plantar Fasciosis, Achilles Tendinosis | Phase 4 | Status: WITHDRAWN